Skip to Main Content

March 17, 2023    
Health Law Weekly

U.S. Court in Pennsylvania Allows Whistleblower Action Against CVS Alleging Medicare Drug Fraud

  • March 17, 2023

A federal court in Pennsylvania refused March 10 to dismiss the bulk of a whistleblower action against CVS Health Corporation and related entities alleging they engaged in an anticompetitive scheme to boost profits that prevented Medicare Part D recipients from accessing less expensive generic drugs.


You must be logged in to access this content.